Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3-4
|
pubmed:dateCreated |
1991-5-14
|
pubmed:abstractText |
The effect of Etodolac on glycosaminoglycan (GAG) synthesis by human synovial cells and rabbit articular chondrocytes in culture was studied at doses ranging from 0.01 to 10 micrograms/ml. In chondrocyte cultures, short-term exposure to Etodolac decreased the total amount of GAGs (mainly chondroitin sulfate) affecting essentially the cell layer-associated fraction. When cells were incubated with Interleukin-1 (IL-1), Etodolac still exerted its inhibiting effect on GAG synthesis. Long-term exposure of chondrocytes to Etodolac caused a diminution of the total GAG synthesis for the highest concentration studied (1 micrograms/ml). IL-1 alone or in combination with Etodolac decreased the synthesis of GAGs suggesting that pretreatment with Etodolac cannot prevent the action of IL-1. In synoviocyte cultures, the drug caused an inhibition of the GAG biosynthesis (mainly hyaluronic acid). In presence of IL-1, Etodolac at the highest concentration partially diminished the stimulatory effect of IL-1. A 8-day exposure of the cells to Etodolac led to a decrease of GAG synthesis. In the same experiment, IL-1 alone caused a slight increase of GAG production that was not abolished by Etodolac treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Etodolac,
http://linkedlifedata.com/resource/pubmed/chemical/Glycosaminoglycans,
http://linkedlifedata.com/resource/pubmed/chemical/Indoleacetic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0065-4299
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
358-67
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2150741-Animals,
pubmed-meshheading:2150741-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:2150741-Cartilage, Articular,
pubmed-meshheading:2150741-Cells, Cultured,
pubmed-meshheading:2150741-Etodolac,
pubmed-meshheading:2150741-Extracellular Matrix,
pubmed-meshheading:2150741-Glycosaminoglycans,
pubmed-meshheading:2150741-Humans,
pubmed-meshheading:2150741-Indoleacetic Acids,
pubmed-meshheading:2150741-Interleukin-1,
pubmed-meshheading:2150741-Rabbits,
pubmed-meshheading:2150741-Rheumatic Diseases,
pubmed-meshheading:2150741-Synovial Membrane
|
pubmed:year |
1990
|
pubmed:articleTitle |
Modulation of extracellular matrix metabolism in rabbit articular chondrocytes and human rheumatoid synovial cells by the non-steroidal anti-inflammatory drug etodolac. II: Glycosaminoglycan synthesis.
|
pubmed:affiliation |
Laboratoire de Biochimie du Tissu Conjonctif, C.H.U. Côte de Nacre, Caen, France.
|
pubmed:publicationType |
Journal Article
|